PT Merck Tbk (IDX:MERK)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
3,620.00
0.00 (0.00%)
May 28, 2025, 4:05 PM WIB
-9.27%
Market Cap 1.62T
Revenue (ttm) 1.00T
Net Income (ttm) 143.00B
Shares Out 448.00M
EPS (ttm) 319.20
PE Ratio 11.34
Forward PE n/a
Dividend 320.00 (8.84%)
Ex-Dividend Date Jun 7, 2024
Volume 3,600
Average Volume 12,625
Open 3,630.00
Previous Close 3,620.00
Day's Range 3,600.00 - 3,630.00
52-Week Range 3,080.00 - 4,400.00
Beta 0.33
RSI 63.01
Earnings Date Aug 5, 2025

About PT Merck Tbk

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, m... [Read more]

Sector Healthcare
Founded 1970
Employees 376
Stock Exchange Indonesia Stock Exchange
Ticker Symbol MERK
Full Company Profile

Financial Performance

In 2024, PT Merck Tbk's revenue was 1.04 trillion, an increase of 7.83% compared to the previous year's 961.43 billion. Earnings were 153.46 billion, a decrease of -13.90%.

Financial Statements

News

There is no news available yet.